Recent reports have shown an increase in the number of organ donors from drug intoxication. The impact of donor drug use on survival after cardiac transplant remains unclear. The aim of our study was to illustrate changes in donor death mechanisms and assess the impact on posttransplant survival. We queried United Network of Organ Sharing thoracic transplant and deceased donor databases to identify patients undergoing heart transplantation between 2005 and 2015. We evaluated annual trends in donor death mechanisms. Recipients were propensity matched (drug-intoxicated-non-drugintoxicated = 1:2) and posttransplant survival was compared using Kaplan-Meier curves.
In total, 19 384 donor hearts were used for transplant during the period (donor age 31.6 ± 11.8 years, 72% male). Use of drug-intoxicated donors increased from 2% (2005) to 13% (2015) and decreased from blunt injury (40%-30%) and intracranial hemorrhage (29%-25%). After propensity matching, posttransplant survival of drug-intoxicated donor hearts was 90%, 82%, and 76% at 1, 3, and 5 years, which was similar to non-drugintoxicated. Heart transplants using drug-intoxicated donors have significantly increased; however, they have not adversely affected posttransplant survival. Hearts from drug-intoxicated donors should be carefully evaluated and considered for transplant.
K E Y W O R D S
alcoholism and substance abuse, cardiovascular disease, clinical decision-making, clinical research/practice, donors and donation: deceased, donors and donation: donor evaluation, heart transplantation/cardiology, organ procurement and allocation affected if chosen selectively. 11, 12 The impact of the drug epidemic has not been well described in cardiac transplant. Using the United Network for Organ Sharing (UNOS) deceased donor data, we aimed to illustrate changes in heart transplant donor death mechanisms and assess the impact of drug-intoxicated donor heart use on posttransplant survival.
| PATIENTS AND ME THODS

| Data and study population
After approval from the University of Louisville Institutional
Review Board, we queried the UNOS deceased donor and thoracic transplant databases to identify organs being evalu- estimates were used for continuous and categorical variables, respectively, to compare baseline characteristics between the study groups. Table 1 shows several differences at baseline between the study groups. A logistic regression model was generated using factors in Table 1 that were significantly different between the study groups to assign a propensity score to each patient for their likelihood of being in either study group. Using this propensity score, the patients in the drug-intoxicated group were matched to the non-drug-intoxicated group with a ratio of 1:2. Table 2 shows the differences in baseline characteristics between the study groups in the propensity-matched cohort.
The primary study end point was actuarial posttransplant graft survival. Kaplan-Meier curves were used to evaluate the survival of both unmatched and propensity-matched cohorts and were compared between the study groups using log-rank test. All statistical analysis was performed using SAS 9.4 software (Cary, NC) at 95%
confidence interval.
Drug-intoxicated donor (n = 1199)
Non-drug-intoxicated donor (n = 2337) P value
Donor characteristics
Age (y) (mean ± SD) 29. Through the first quarter of 2015, 532 transplants had been performed. Donors had a mean age of 31.6 ± 11.8 years and were more likely to be male (72%). The most common causes of donor death, which is distinct from mechanism of death, were head trauma (60%), cerebrovascular (23%), anoxia (16%), tumor (0.4%), and other (1%).
| Donor mechanisms
The most common mechanisms of donor death during the study period were blunt injury (36.5%), intracranial hemorrhage/stroke (25.3%), gunshot (20.6%), drug intoxication (6.4%), cardiovascular (6.3%), and asphyxiation (3.9%). Figure 1 shows the annual proportions of donor 5.2% to 9.7% of total heart transplants performed in a recipient's organ procurement organization.
| Donor and recipient characteristics
Characteristics of drug-intoxicated and non-drug-intoxicated donors used for transplant and the corresponding recipients in the unmatched cohort are compared in Table 1 . Drug-intoxicated donors more frequently required cardiopulmonary resuscitation (15% vs 6%) and had greater median peak troponin (0.9 vs 0.28 ng/mL). Drug-intoxicated donors were more likely to be designated by the Public Health Service as having an increased risk of bloodborne disease transmission (43% vs 10%). Additionally, they
were more likely to be female, smokers, and have a higher creatinine level. Drug-intoxicated donor ischemic time (3.3 ± 1.0 hours) and sex mismatch (27%) did not differ from non-drug-intoxicated donors (3.2 ± 1.0 hours and 25%, respectively). Among donors whose organs were accepted for transplant, drug-intoxicated donors had an ejection fraction (EF) of 60 ± 7%, age of 29 ± 9 years, and body mass index (BMI) of 27 ± 6 kg/m 2 , which was statistically 
| Propensity matching
To account for differences in demographics and risk factors between the drug-intoxicated and non-drug-intoxicated donor groups, a propensity matching was performed with a ratio of 1:2. There were 1199 in the drug-intoxicated group and 2337 patients in the nondrug-intoxicated group after propensity matching. This resulted in a well-matched cohort except for age and creatinine, which were clinically similar (Table 2) .
| Survival and outcomes
Kaplan-Meier analyses showed that posttransplant survival was not significantly different between recipients of drug-intoxicated and non-drug-intoxicated donor hearts in the unmatched (P = .5) and matched (P = .16) cohorts ( Figure 4A,B) . In the matched cohort, survival of patients receiving hearts from drug-intoxicated donors was 90%, 82%, and 76% at 1, 3, and 5 years, which was similar to organs accepted from non-drug-intoxicated donors (89%, 81%, and 74%). Rates of acute rejection in the first year were similar between groups in the matched cohort (17% vs 18%) as were the most common posttransplant causes of death (Table 3) . Posttransplant mortality associated with bloodborne viral diseases, which includes hepatitis and liver failure, were <1% in both groups. During posttransplant follow-up, 9% of drug-intoxicated donor and 12% nondrug-intoxication donor recipients had coronary artery disease, which may be used as a surrogate for cardiac allograft vasculopathy.
| D ISCUSS I ON
The opioid epidemic has tragically led to thousands of untimely deaths, as drug overdose has become the leading cause of accidental adult death. 6 As a group, this new source of donor organs has contributed to the increasing number of cardiac transplants since 2010
and has the highest rate of at least 1 organ donated. 3, 13 Our study showed a similar increase in use of drug-intoxicated donors.
The absolute number and portion of heart transplantations from We observed that recipient characteristics including age, heart failure cause, and renal function were clinically similar between those receiving drug-intoxicated hearts compared to non-drug-intoxicated hearts. Recipients of drug-intoxicated donor organs could be considered "sicker" as they were more likely to be listed as status IA apprehension from both transplant providers and patients who feel that risk of transmission was acceptable only as a last resort. 10, 14 The reasons for hesitancy in transplanting donor organs with history of drug use includes concerns for transmission of bloodborne illnesses such as hepatitis C, hepatitis B, and human immunodeficiency virus. 15 Historically, hepatitis C transmission rates have been reported in excess of 80%, which resulted in increased mortality from liver disease and coronary vasculopathy. 16, 17 This preceded the availability of curative antiviral treatment, which has shown encouraging results in kidney and liver recipients, and is now being trialed in cardiac transplantation. 18 Our study not only demonstrated similar rates of deaths caused by viral infections and liver failure in both of the study groups, but also showed no difference in acute causes of death or rejection during the first year after transplant.
Our findings of equivalent posttransplant survival between drugintoxicated donors and all others are supported by previously studies evaluating donors with high-risk social behaviors. 19, 20 Peak troponin was elevated in the drug-intoxicated donor group but did not impact survival, which was previously shown in a study by Boeken et al. 21 Similar to our study, Pruett et al previously showed that survival was not diminished using donors designated by the Public Health Service as having an increased risk of bloodborne disease transmission. 20 Predictors of an organ being turned down in the drug-intoxicated group including reduced EF, older age, and increased peak troponin are similar to reported factors. 9 Importantly, this study illustrates that organs accepted from drug-intoxicated donors do not diminish survival nor do they result in increased acute rejection at 1 year.
This a retrospective study of a national database and inherently has many limitations, which includes inability to control for confounding factors; thus, we are unable to validate accuracy of information entered into the database, and our analyses are restricted to only variables collected. We would have chosen to include additional factors in our study including chronic drug use and drug use at the time of death. The UNOS database does not included certain factors, which would have allowed for additional analyses including program tolerance for drug-intoxicated donor organs, program volume, and surgeon variability. Use of a retrospective database exposes this study to selection bias, and we are unable to determine the number of potential drug-intoxicated donor hearts declined that may have otherwise been used for transplantation.
The UNOS database does not include the information necessary to delineate between pharmacologic classes causing intoxication (ie, opioids, amphetamines, alcohol). However, recent data suggest that opioid overdose accounts for more than half of drug-intoxicated donor deaths. 22 Moreover, it is not possible to delineate between overlapping death mechanisms. For example, an alcohol-intoxicated donor in a motor vehicle accident could have their death mechanism entered as either blunt trauma or drug intoxication.
In conclusion, hearts from drug-intoxicated donors have been increasingly used for transplantation over the past decade. Donor hearts from individuals who died because of drug intoxication have similar posttransplant survival compared to hearts from donors who died of other mechanisms, even though recipients were more likely to be listed as IA or to require mechanical circulatory support. This suggests that when carefully evaluated, drug-intoxicated donor hearts can increase the donor pool and decrease waitlist mortality.
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